MCID: TLG001
MIFTS: 26

Telogen Effluvium

Categories: Skin diseases

Aliases & Classifications for Telogen Effluvium

MalaCards integrated aliases for Telogen Effluvium:

Name: Telogen Effluvium 12 15 74

Classifications:



External Ids:

Disease Ontology 12 DOID:1943
ICD9CM 36 704.02
NCIt 51 C112200
SNOMED-CT 69 39479004
ICD10 34 L65.0
UMLS 74 C0263518

Summaries for Telogen Effluvium

MalaCards based summary : Telogen Effluvium is related to alopecia and androgenic alopecia. An important gene associated with Telogen Effluvium is DLGAP3 (DLG Associated Protein 3). The drugs Antiviral Agents and Ammonium trichloro(dioxoethylene-O,O'-)tellurate have been mentioned in the context of this disorder. Affiliated tissues include skin, spinal cord and thyroid.

Wikipedia : 77 Telogen effluvium is a scalp disorder characterized by the thinning or shedding of hair resulting from... more...

Related Diseases for Telogen Effluvium

Diseases related to Telogen Effluvium via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 21)
# Related Disease Score Top Affiliating Genes
1 alopecia 10.8
2 androgenic alopecia 10.7
3 alopecia, androgenetic, 1 10.7
4 alopecia areata 10.6
5 dermatitis 10.4
6 contact dermatitis 10.4
7 anxiety 10.2
8 crohn's disease 10.2
9 spinal cord injury 10.2
10 iron metabolism disease 10.2
11 allergic contact dermatitis 10.2
12 hodgkin's lymphoma, lymphocytic-histiocytic predominance 10.2
13 psoriasis 10.2
14 eosinophilia-myalgia syndrome 10.2
15 pustular psoriasis 10.2
16 levocardia 10.2
17 trichotillomania 9.9 DLGAP3 SLITRK1
18 impulse control disorder 9.9 DLGAP3 SLITRK1
19 follicular mucinosis 9.8 DLGAP3 SLITRK1
20 obsessive-compulsive disorder 9.7 DLGAP3 SLITRK1
21 stereotypic movement disorder 9.7 SLITRK1 TAC1

Graphical network of the top 20 diseases related to Telogen Effluvium:



Diseases related to Telogen Effluvium

Symptoms & Phenotypes for Telogen Effluvium

Drugs & Therapeutics for Telogen Effluvium

Drugs for Telogen Effluvium (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 8)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1 Antiviral Agents Phase 2
2 Ammonium trichloro(dioxoethylene-O,O'-)tellurate Phase 2
3 Anti-Infective Agents Phase 2
4 Adjuvants, Immunologic Phase 2
5 Immunologic Factors Phase 2
6 Radiation-Protective Agents Phase 2
7 Protective Agents Phase 2
8 Plasminogen Activator Inhibitor 1

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Efficacy and Safety of Neosil on Chronic Effluvium Recruiting NCT03659201 Phase 4 Neosil complete;Pantogar;Neosil
2 Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women Unknown status NCT00418249 Phase 2 AS101
3 Evaluation of Tolerance and Trichological Efficacy of a Food Supplement Completed NCT03272750 Not Applicable
4 PAI-1 Expression in Non-scarring Hair Loss Recruiting NCT02548689
5 Demonstration of Carbonyl Stress on Hair Follicles Not yet recruiting NCT03414476 Not Applicable

Search NIH Clinical Center for Telogen Effluvium

Genetic Tests for Telogen Effluvium

Anatomical Context for Telogen Effluvium

MalaCards organs/tissues related to Telogen Effluvium:

42
Skin, Spinal Cord, Thyroid

Publications for Telogen Effluvium

Articles related to Telogen Effluvium:

(show top 50) (show all 88)
# Title Authors Year
1
Treatment of Telogen Effluvium using a dietary supplement containing Boswellia serrata, Curcuma longa and Vitis Vinifera: results of an observational study. ( 30693615 )
2019
2
Research on the Balance of Thiol-Disulfide in Blood Serum in Women with Telogen Effluvium. ( 30820129 )
2019
3
Beau lines and telogen effluvium following aluminium phosphide poisoning. ( 30845132 )
2019
4
Telogen Effluvium: Is There a Need for a New Classification? A Reply. ( 29457010 )
2018
5
A proprietary herbal extract against hair loss in androgenetic alopecia and telogen effluvium: a placebo-controlled, single-blind, clinical-instrumental study. ( 29945259 )
2018
6
Assessment of Heavy Metal and Trace Element Levels in Patients with Telogen Effluvium. ( 29937562 )
2018
7
Localized Telogen Effluvium Following Hair Transplantation. ( 29606820 )
2018
8
Color-transition sign: A useful trichoscopic finding for differentiating alopecia areata incognita from telogen effluvium. ( 29512186 )
2018
9
HrQoL in hair loss-affected patients with alopecia areata, androgenetic alopecia and telogen effluvium: the role of personality traits and psychosocial anxiety. ( 30394586 )
2018
10
Comparative evaluation between two nutritional supplements in the improvement of telogen effluvium. ( 30237729 )
2018
11
Telogen Effluvium With Dysesthesia (TED) Has Lower B12 Levels and May Respond to B12 Supplementation ( 30500148 )
2018
12
Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study. ( 29167734 )
2017
13
Telogen Effluvium ( 28613598 )
2017
14
Postfebrile telogen effluvium. ( 28704990 )
2017
15
Presence of Mast Cells and Mast Cell Degranulation in Scalp Biopsies of Telogen Effluvium. ( 28761261 )
2017
16
Suprabulbar Thinning of Hair in Telogen Effluvium. ( 28332382 )
2017
17
Intermittent Chronic Telogen Effluvium. ( 28612000 )
2017
18
Telogen Effluvium: Is There a Need for a New Classification? ( 27843921 )
2016
19
Proposing a Simpler Classification of Telogen Effluvium. ( 27843920 )
2016
20
Hormones and clocks: do they disrupt the locks? Fluctuating estrogen levels during menopausal transition may influence clock genes and trigger chronic telogen effluvium. ( 27617515 )
2016
21
The Postpartum Telogen Effluvium Fallacy. ( 27386466 )
2016
22
Vitamin and Mineral Deficiencies in Patients With Telogen Effluvium: A Retrospective Cross-Sectional Study. ( 27741341 )
2016
23
Scalp Psoriasiform Contact Dermatitis with Acute Telogen Effluvium due to Topical Minoxidil Treatment. ( 27172052 )
2016
24
Telogen Effluvium: A Review. ( 26500992 )
2015
25
Localized telogen effluvium after face lift surgery. ( 25673954 )
2015
26
Non-invasive method distinguishes chronic telogen effluvium from mild female pattern hair loss: clinicopathological correlation. ( 26711442 )
2015
27
Postpartum telogen effluvium. ( 25600276 )
2015
28
Drug-induced Telogen Effluvium in a Pediatric Patient due to Error of Transcription. ( 26346096 )
2015
29
Possible Relationship between Chronic Telogen Effluvium and Changes in Lead, Cadmium, Zinc, and Iron Total Blood Levels in Females: A Case-Control Study. ( 26622152 )
2015
30
Telogen effluvium as first clinical presentation of dengue. ( 25800885 )
2015
31
Female pattern alopecia and telogen effluvium: figuring out diffuse alopecia. ( 26176282 )
2015
32
Chronic telogen effluvium and female pattern hair loss are separate and distinct forms of alopecia: a histomorphometric and immunohistochemical analysis. ( 25156792 )
2014
33
Telogen effluvium as the first symptom of Crohn's disease in a child. ( 25330758 )
2014
34
Acute telogen effluvium onset event is associated with the presence of female androgenetic alopecia: potential therapeutic implications. ( 24850277 )
2014
35
Telogen effluvium revisited. ( 24566565 )
2014
36
Analysis of clinical and histologic correlations in alopecia areata and telogen effluvium: adversities in alopecia pattern mimicry. ( 23617085 )
2013
37
Telogen effluvium. ( 23974577 )
2013
38
Telogen effluvium need not recur. ( 25611604 )
2013
39
Clinical severity does not reliably predict quality of life in women with alopecia areata, telogen effluvium, or androgenic alopecia. ( 21601948 )
2012
40
Telogen effluvium following bivalent human papillomavirus vaccine administration: a report of two cases. ( 22584489 )
2012
41
Oral zinc therapy for zinc deficiency-related telogen effluvium. ( 22741940 )
2012
42
Clinical and histological challenge in the differential diagnosis of diffuse alopecia: female androgenetic alopecia, telogen effluvium and alopecia areata - part I. ( 23044568 )
2012
43
Telogen effluvium after oral albendazole. ( 22420487 )
2012
44
Clinical and histological challenge in the differential diagnosis of diffuse alopecia: female androgenetic alopecia, telogen effluvium and alopecia areata--part II. ( 23197208 )
2012
45
Iron deficiency in female pattern hair loss, chronic telogen effluvium, and control groups. ( 20947203 )
2010
46
Thyroid peroxidase antibodies in patients with telogen effluvium. ( 20202052 )
2010
47
Chronic telogen effluvium is due to a reduction in the variance of anagen duration. ( 20695853 )
2010
48
Trichodynia is a distinguishing symptom of telogen effluvium. ( 19281607 )
2009
49
Telogen effluvium following orthognathic surgery. ( 17577511 )
2007
50
Hirsutism, postpartum telogen effluvium, and male pattern alopecia. ( 17173578 )
2006

Variations for Telogen Effluvium

Expression for Telogen Effluvium

Search GEO for disease gene expression data for Telogen Effluvium.

Pathways for Telogen Effluvium

GO Terms for Telogen Effluvium

Biological processes related to Telogen Effluvium according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cell-cell signaling GO:0007267 8.62 SRD5A2 TAC1

Sources for Telogen Effluvium

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....